Motor neurone disease onset delayed by AI-discovered drug
European Pharmaceutical Review | May 25, 2017
The Sheffield Institute for Translational Neuroscience (SITraN), part of the University of Sheffield and one of the world’s leading centres for research into Motor Neurone Disease, Alzheimer’s and Parkinson’s Disease.